切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2021, Vol. 15 ›› Issue (05) : 365 -369. doi: 10.3877/cma.j.issn.1674-0785.2021.05.010

临床研究

中性粒细胞/淋巴细胞比值、纤维蛋白原在食管癌诊断中的价值
汪帅1, 李红玲1,()   
  1. 1. 223001 江苏淮安,徐州医科大学附属淮安医院消化科
  • 收稿日期:2021-01-06 出版日期:2021-05-15
  • 通信作者: 李红玲

Diagnostic value of neutrophil-to-lymphocyte ratio and fibrinogen in esophageal cancer

Shuai Wang1, Hongling Li1,()   

  1. 1. Department of Gastroenterology, Huai'an Hospital Affiliated to Xuzhou Medical University, Huai'an 223001, China
  • Received:2021-01-06 Published:2021-05-15
  • Corresponding author: Hongling Li
引用本文:

汪帅, 李红玲. 中性粒细胞/淋巴细胞比值、纤维蛋白原在食管癌诊断中的价值[J]. 中华临床医师杂志(电子版), 2021, 15(05): 365-369.

Shuai Wang, Hongling Li. Diagnostic value of neutrophil-to-lymphocyte ratio and fibrinogen in esophageal cancer[J]. Chinese Journal of Clinicians(Electronic Edition), 2021, 15(05): 365-369.

目的

探讨外周血中性粒细胞/淋巴细胞比值(NLR)、纤维蛋白原(FIB)在食管癌(EC)诊断中的价值,分析NLR、FIB与EC临床病理分期的关系。

方法

收集2017年6月至2020年6月徐州医科大学附属淮安医院收治的EC患者224例,EC癌前病变患者79例,胃-食管反流病(GERD)患者218例,另选取健康对照者214例。比较4组患者NLR、FIB、癌胚抗原(CEA)水平差异;利用受试者工作特征曲线(ROC)计算NLR、FIB、CEA诊断EC的曲线下面积(AUC),得出最佳截断值及敏感度与特异度;分析NLR、FIB、CEA水平与EC患者TNM分期的关系。

结果

EC组NLR、FIB明显高于EC癌前病变组、GERD组及对照组(P<0.05);EC组CEA明显高于GERD组及对照组(P<0.05),CEA在EC组与癌前病变组间比较,差异无统计学意义(P>0.05);EC癌前病变组NLR、FIB、CEA均高于对照组(P<0.05),与GERD组比较差异均无统计学意义(P>0.05);NLR、FIB、CEA 3个指标之中,只有NLR在GERD组和对照组间差异有统计学意义(P<0.05)。NLR、FIB、CEA诊断EC的AUC值分别为0.76、0.73、0.61,最佳截断值分别为2.48、2.75 g/L、2.06 ng/ml,敏感度分别为72.8%、65.3%、62.0%,特异度分别为64.3%、69.0%、59.2%,NLR、FIB诊断效力优于CEA(P<0.05),而NLR与FIB的诊断效力无明显差异(P>0.05)。NLR、FIB水平在不同的食管癌TNM分期中存在显著性差异(P<0.05)。经相关性分析,NLR、FIB、CEA均与食管癌分期呈正相关(r=0.25、0.19、0.19,P<0.05)。

结论

外周血NLR、FIB水平在EC患者中显著升高,NLR、FIB对EC的诊断效能优于CEA,NLR、FIB水平与EC的临床病理分期相关。

Objective

To evaluate the value of neutrophil-to-lymphocyte ratio (NLR) and fibrinogen (FIB) in the diagnosis of esophageal cancer (EC), and analyze the relationship of NLR and FIB with clinicopathological stages of EC.

Methods

A total of 224 patients with EC, 79 patients with precancerous EC lesions, and 218 patients with gastroesophageal reflux disease (GERD) were enrolled at Huai'an Hospital Affiliated to Xuzhou Medical University from June 2017 to June 2020, and 214 healthy controls were also included. The levels of NLR, FIB, and carcinoembryonic antigen (CEA) in the four groups were compared, and the areas under the receiver operating characteristic curves (AUCs) of NLR, FIB, and CEA in the diagnosis of EC were calculated, and the best cutoff value, sensitivity, and specificity were obtained. Finally, the relationship of the levels of NLR, FIB, and CEA with TNM stage in EC patients was analyzed.

Results

NLR and FIB in the EC group were significantly higher than those in the other three groups (P<0.05). CEA in the EC group was significantly higher than those in the GERD group and control group (P<0.05), but there was no significant difference in CEA between the EC group and precancerous lesion group (P>0.05). NLR, FIB, and CEA in the EC precancerous lesion group were significantly higher than those of the control group (P<0.05), but there was no statistical difference between EC precancerous lesion group and GERD group (P>0.05). Among the NLR, FIB, and CEA, only NLR showed a statistically significant difference between the GERD group and control group (P<0.05). The AUCs of NLR, FIB, and CEA in the diagnosis of EC were 0.76, 0.73, and 0.61; the best cutoff values were 2.48, 2.75 g/L, and 2.06 ng/ml; the sensitivities were 72.8%, 65.3%, and 62.0%; and the specificities were 64.3%, 69.0%, and 59.2%, respectively. The diagnostic efficacy of NLR and FIB was better than that of CEA (P<0.05), but there was no significant difference between NLR and FIB (P>0.05). The levels of NLR and FIB were significantly different among different TNM stages of EC (P<0.05). Correlation analysis showed that NLR, FIB, and CEA were positively correlated with EC stage (r=0.25, 0.19, and 0.19, respectively, P<0.05).

Conclusion

NLR and FIB in peripheral blood significantly increase in patients with EC. The diagnostic efficacy of NLR and FIB in EC is better than that of CEA, and the levels of NLR and FIB correlate with the clinicopathological stage of EC.

表1 各组NLR、FIB、CEA水平比较[MQ25Q75)]
图1 NLR、FIB、CEA诊断EC的ROC曲线
表2 NLR、FIB、CEA诊断EC的效能情况
表3 EC不同TNM分期与NLR、FIB、CEA的关系
[M(Q25,Q75)]
1
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2018, 68(6): 394-424.
2
Shapiro J, van Lanschot JJB, MCCM Hulshof, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial [J]. Lancet Oncol, 2015, 16(9): 1090-1098.
3
王建飞, 钟理. 食管癌肿瘤相关自身抗体研究进展 [J]. 现代免疫学, 2009, 29(5): 435-437.
4
卢晨, 于在诚. 食管癌相关血清肿瘤标志物的临床应用 [J]. 安徽医科大学学报, 2013, 48(2): 192.
5
Huang Y, Sun Y, Peng P, et al. Prognostic and clinicopathologic significance of neutrophil-to-lymphocyte ratio in esophageal squamous cell carcinoma: evidence from a meta-analysis [J]. Onco Targets Ther, 2017, 10: 1165-1172.
6
Son HJ, Park JW, Chang HJ, et al. Preoperative plasma hyperfibrinogenemia is predictive of poor prognosis in patients with nonmetastatic colon cancer [J]. Ann Surg Oncol, 2013, 20(9): 2908-2913.
7
Sheng L, Luo M, Sun X, et al. Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancer [J]. Int J Cancer, 2013, 133(11): 2720-2725.
8
Fouad TM, Barrera AMG, Reuben JM, et al. Inflammatory breast cancer: a proposed conceptual shift in the UICC-AJCC TNM staging system [J]. Lancet Oncol, 2017, 18(4): e228-e232.
9
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2018, 68: 394-424.
10
Enzinger PC, Mayer RJ. Esophageal cancer [J]. N Engl J Med, 2003, 349(23): 2241-2252.
11
Liu JS, Huang Y, Yang X, et al. Anomogram to predict prognostic values of various inflammatory biomarkers in patients with esophageal squamous cell carcinoma [J]. Am J Cancer Res, 2015, 5(7): 2180-2189.
12
Grenader T, Plotkin Y, Mohammadi B, et al. Predictive value of the neutrophil-lymphocyte ratio in peritoneal and/or metastatic disease a staging laparoscopy for gastric and esophageal adenocaroinoma [J]. J Gastrointest Cancer, 2015, 46(3): 267-271.
13
Steinbrecher KA, Horowitz NA, Blevins EA, et al. Colitis-associated canceris dependent on the interplay between the hemostatic and inflammatory systems and supported by integrin alpha (M) beta (2) engagement of fibrinogen [J]. Cancer Res, 2010, 70(7): 2634-2643.
14
Han F, Liu Y, Cheng S, et al. Diagnosis and survival values of neutrophil-lymphocyte ratio (NLR) and red blood cell distribution width (RDW) in esophageal cancer [J]. Clin Chim Acta, 2018, 488: 150-158.
15
Wakatsuki K, Matsumoto S, Migita K, et al. Preoperative plasma fibrinogen is associated with lymph node metastasis and predicts prognosis in resectable esophageal cancer [J]. World J Surg, 2017, 41(8): 2068-2077.
16
Yu X, Hu F, Yao Q, et al. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study [J]. BMC Cancer, 2016, 16(1): 1-12.
17
郑森中, 陈魏, 牟吉, 等. 术前系统免疫炎症指数和中性粒细胞/淋巴细胞比值与食管癌临床病理特征及预后的关系 [J]. 中国卫生检验志, 2019, 29(7): 818-822.
[1] 魏徐, 张鸽, 伍金林. 新生儿脓毒症相关性凝血病的监测和治疗[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 379-386.
[2] 高加林, 曹亚娟. 腹腔镜解剖性肝右后叶切除治疗食管癌根治术后孤立性肝转移[J]. 中华腔镜外科杂志(电子版), 2023, 16(04): 239-242.
[3] 施我大, 张亚军, 施展, 吴纪祥, 常绘文, 易忠权, 梁晓东, 周晶晶, 宋建祥. Treg细胞通过上调TGF-β1和B7-H3表达促进食管癌细胞增殖、迁移和侵袭[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(02): 65-75.
[4] 王静, 何彬. 经颅彩色多普勒超声联合血sCD40L、Fib、PAF对短暂性脑缺血发作后脑梗死的预测效果[J]. 中华神经创伤外科电子杂志, 2023, 09(04): 222-227.
[5] 单秋洁, 孙立柱, 徐宜全, 王之霞, 徐妍, 马浩, 刘田田. 中老年食管癌患者调强放射治疗期间放射性肺损伤风险模型构建及应用[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 388-393.
[6] 侯超, 潘美辰, 吴文明, 黄兴广, 李翔, 程凌雪, 朱玉轩, 李文波. 早期食管癌及上皮内瘤变内镜黏膜下剥离术后食管狭窄的危险因素[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 383-387.
[7] 苏鹏, 吕会来, 温士旺, 黄超, 张缜, 田子强. 全腔镜下食管癌根治术围手术期呼吸系统并发症发生的危险因素分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 294-298.
[8] 曹旬旬, 费素娟. 食管癌患者肿瘤组织CXCL5和CXCR2的表达与病情和预后的相关性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 299-304.
[9] 屠松霞, 郑红艳, 朱姝, 徐夏君. 食管癌术后患者肠内营养耐受不良的影响因素及列线图风险模型[J]. 中华消化病与影像杂志(电子版), 2023, 13(02): 73-77.
[10] 陈柯豫, 黄艳齐, 张玲利. 同时性多发早期食管癌及高级别上皮内瘤变的危险因素分析[J]. 中华临床医师杂志(电子版), 2023, 17(05): 524-528.
[11] 孙天宇, 王如文, 蒋彬. 食管碰撞癌1例[J]. 中华胸部外科电子杂志, 2023, 10(04): 238-240.
[12] 李正龙, 赵永生, 罗钶鑫, 彭忠勤. 胸腔镜切除治疗全内脏反位合并食管癌手术1例并文献复习[J]. 中华胸部外科电子杂志, 2023, 10(04): 234-237.
[13] 秦建军, 郭旭峰, 胡杨, 李向楠, 李卓毅, 林江波, 梅新宇, 唐鹏, 王长春, 王枫, 王洪琰, 尹俊, 袁勇, 赵晋波, 李志刚, 李印. 日本2022版食管癌诊治指南在中国的接受度——中国红杉树专家调研[J]. 中华胸部外科电子杂志, 2023, 10(04): 195-199.
[14] 李国仁, 戴建华. 我国食管癌治疗理念与模式的沿革和进展[J]. 中华胸部外科电子杂志, 2023, 10(02): 117-125.
[15] 朱开元, 李志刚. 食管癌术后吻合口瘘临床管理进展[J]. 中华胸部外科电子杂志, 2023, 10(01): 50-56.
阅读次数
全文


摘要